Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 5 | 0 | €693.20 | €755.83 | 9.035% |
| Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | €367.00 | €382.71 | 4.279% |
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €839.60 | €954.29 | 13.661% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €117.80 | €124.92 | 6.040% |
| Trinity Biotech ADR | 24 | 0 | 3 | 0 | €0.41 | - | - |
| Amgen Inc. | 23 | 0 | 3 | 0 | €246.90 | €293.65 | 18.934% |
| Cytokinetics Inc. | 24 | 1 | 4 | 0 | €62.00 | €88.82 | 43.263% |
| Intra-Cellular Therapies Inc. | 21 | 0 | 5 | 0 | €68.00 | €77.61 | 14.137% |
| Neurocrine Bioscience | 21 | 0 | 3 | 0 | €125.00 | €137.10 | 9.680% |
| Sutro Biopharma Inc | 18 | 0 | 7 | 0 | €3.50 | €11.05 | 215.669% |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | €84.64 | €102.48 | 21.073% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €6.00 | - | - |
| AbbVie Inc. | 18 | 1 | 3 | 1 | €153.64 | €175.79 | 14.416% |
| Novo Nordisk A/S ADR | 17 | 1 | 5 | 0 | €115.50 | €130.00 | 12.554% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.95 | €22.78 | 108.089% |
| Abbott Laboratories | 17 | 1 | 2 | 0 | €98.44 | €116.71 | 18.563% |
| United Therapeutics | 15 | 0 | 0 | 0 | €222.00 | €289.92 | 30.595% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.44 | €26.01 | 21.299% |
| TG Therapeutics Inc. | 19 | 4 | 3 | 0 | €13.15 | €26.00 | 97.704% |
| Icon plc | 15 | 0 | 3 | 0 | €270.90 | €318.32 | 17.505% |
| Krystal Biotech | 15 | 0 | 2 | 0 | €154.00 | €166.84 | 8.339% |
| EyePoint Pharmaceuticals Inc. | 15 | 1 | 0 | 1 | €16.45 | €28.17 | 71.232% |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 1 | €11.00 | €21.39 | 94.482% |
| G1 Therapeutics | 14 | 1 | 2 | 0 | €3.83 | €10.56 | 175.836% |
| Acorda Therapeutics Cdt | 13 | 0 | 0 | 0 | €0.47 | - | - |